Poseida Therapeutics, Inc.

PSTX · NASDAQ
Analyze with AI
9/30/2024
6/30/2024
3/31/2024
12/31/2023
Assets
Cash & Equivalents$49,340$30,545$53,297$44,472
Short-Term Investments$181,512$207,267$145,349$167,730
Receivables$14,749$12,427$12,027$9,010
Inventory$0$0$0$0
Other Curr. Assets$5,103$4,097$6,059$3,762
Total Curr. Assets$250,704$254,336$216,732$226,475
Property Plant & Equip (Net)$36,420$37,721$39,219$40,781
Goodwill$4,228$4,228$4,228$4,228
Intangibles$1,320$1,320$1,320$1,320
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$905$1,081$1,081$1,081
Total NC Assets$42,873$44,350$45,848$47,410
Other Assets$0$0$0$0
Total Assets$293,577$298,686$262,580$273,885
Liabilities
Payables$5,197$2,990$2,704$3,267
Short-Term Debt$0$6,039$0$5,951
Tax Payable$0$0$0$0
Deferred Revenue$37,273$63,289$49,770$31,008
Other Curr. Liab.$4,340$16,201$21,070$12,065
Total Curr. Liab.$78,269$102,434$84,763$71,318
LT Debt$58,908$58,796$58,691$58,590
Deferred Rev, NC$0$54,924$11,903$16,780
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$51,455$2,897$2,754$2,614
Total NC Liab.$128,097$135,435$93,223$98,866
Other Liabilities$0$0$0$0
Cap. Leases$23,819$18,818$19,875$20,882
Total Liabilities$206,366$237,869$177,986$170,184
Equity
Pref Stock$0$0$0$0
Common Stock$10$10$10$10
Retained Earnings-$629,701-$649,936-$618,565-$594,291
AOCI$376-$82-$47$126
Other Equity$0$0$0$0
Total Equity$87,211$60,817$84,594$103,701
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$293,577$298,686$262,580$273,885
Net Debt$9,568$34,290$5,394$20,069
Poseida Therapeutics, Inc. (PSTX) Financial Statements & Key Stats | AlphaPilot